Table 1.
Gold standard CNVs from 13 clinical samples used to assess Atlas-CNV performance
Sample | Gene | Chr | Start | End | Sizea | cSNP sizeb | Class | Number of ES exons in CNV | Exon range of CNV |
---|---|---|---|---|---|---|---|---|---|
1–100155 | MYH11 | 16 | 15797848 | 15932110 | 134,262 | 815,577 | hetdel | 42 | 2–42c |
2–100159 | MYH11 | 16 | 15797848 | 15932110 | 134,262 | 735,806 | hetdel | 42 | 2–42 |
3–100161 | MYH11 | 16 | 15797848 | 15932110 | 134,262 | 2,104,716 | hetdel | 42 | 2–42 |
4–100171 | MYH11 | 16 | 15797848 | 15932110 | 134,262 | 1,158,489 | hetdel | 42 | 2–42 |
5–100168 | RYR2 | 1 | 237205822 | 237995948 | 790,126 | 4,170,626 | hetdel | 104 | 1–105d |
6–100175 | DSG2 | 18 | 29078215 | 29118942 | 40,727 | 20,632 | hetdel | 12 | 1–12 |
7–100185 | BRCA1 | 17 | 41242961 | 41249307 | 6346 | 5803 | hetdel | 4 | 8–11 |
8–100196 | IL33 | 9 | 6241695 | 6256169 | 14,474 | 232,335 | hetdel | 7 | 1–7 |
9–100199 | MYH7 | 14 | 23882022 | 23889487 | 7465 | 28,302 | hetdel | 14 | 27–40 |
10–100208 | MLH1 (LRRFIP2) | 3 | 37089010 | 37116608 | 27,598 | 27,528 | hetdel | 4 (9) | 16–19 (21–29) |
11–100184 | HNF1B | 17 | 36047375 | 36104876 | 57,501 | 1,351,422 | hetdel | 9 | 1–9 |
12–100189 | HNF1B | 17 | 36047336 | 36104876 | 57,540 | 1,375,039 | hetdel | 9 | 1–9 |
13–100209 | HNF1B | 17 | 36047336 | 36104876 | 57,540 | 1,375,039 | hetdel | 9 | 1–9 |
All CNVs are heterozygous deletions and were previously identified in ES and Illumina HumanExome-12v array with the exception of sample 13, which has no ES.
CNV copy-number variant, ES exome sequencing.
aCNV size from clinical ES.
bCNV size from Illumina HumanExome-12v array.
cMHY11 exon 42 has 2 targets in ES data.
dRYR2 exon 91 is absent in ES.